loader

Disclaimer

The Bar Council of India does not permit advertisement or solicitation by advocates in any form or manner. By accessing this website, www.khaitanco.com, you acknowledge and confirm that you are seeking information relating to Khaitan & Co of your own accord and that there has been no form of solicitation, advertisement or inducement by Khaitan & Co or its members. The content of this website is for informational purposes only and should not be interpreted as soliciting or advertisement. No material/information provided on this website should be construed as legal advice. Khaitan & Co shall not be liable for consequences of any action taken by relying on the material/information provided on this website. The contents of this website are the intellectual property of Khaitan & Co.

Please accept the above
Close

Search

See all results for ""
MA

Mukul Aggarwal

, Delhi - NCR

Partner | Corporate & Commercial, Venture Capital, Private Equity

education

  • Master of Corporate Law (2019), University of Cambridge
  • B.Sc. - LL.B. (Hons.) (2012) National Law University, Jodhpur

Mukul Aggarwal is a Partner in the Corporate and Commercial practice at the firm’s NCR office. With nearly 13 years of experience, he specialises in private equity, venture capital, and acquisition transactions, advising investors, companies, and founders across diverse sectors. Mukul has been recognised as a “Recommended and Key Lawyer” for Life Sciences and Healthcare by Legal 500 Asia-Pacific 2025.

Professional Affiliations

  • Bar Council of Delhi

Representative Matters

Mukul Aggarwal has represented and advised the following clients

Peak XV Partners

Advised on sale of their securities in Uprising Science Private Limited (Minimalist) to Hindustan Unilever Limited for a deal value of INR 30 billion

Quadria Capital Advisors Private Limited

Advised on its investment of (i) INR 9 billion in Nephrocare Health Services Private Limited, and (ii) up to INR 13 billion in Maxivision Eye Hospitals Private Limited, through primary investment and secondary acquisition

Clove Dental

Advised on its USD 50 million Series D1 funding round led by QIA

Euler Motors Private Limited

Advised on its USD 60 million Series C funding round led by GIC Singapore

AdvantEdge Technology Fund and Micelio Technology Fund

Advised on their investment in the Series Seed funding round of Moonrider Private Limited

Lightspeed India

Advised on its investments in (i) the Series A round of Exponent Energy Private Limited, (ii) Series C round of Healthplix (a company providing digital platform for doctors), (iii) USD 20 million Series B round of Zluri Technologies Private Limited (a company providing SaaS management platform